Blog
RSS FeedPosted by Michael Wonder on 19 Dec 2016
A message from the Panel - Review of Pharmacy Remuneration and Regulation
19 December 2016 - In their final communication for the year, the Independent Review Panel conducting the Review of Pharmacy Remuneration ...
Posted by Michael Wonder on 19 Dec 2016
National Health Amendment (Pharmaceutical Benefits) Bill 2016
19 December 2016 - The National Health Amendment (Pharmaceutical Benefits) Bill 2016 was introduced into the House of Representatives on ...
Posted by Michael Wonder on 18 Dec 2016
Summary of submissions and outcomes from the November 2016 PBAC meeting
19 December 2016 - 70 submissions were considered at the July 2016 PBAC meeting (this includes submissions relating to “Other ...
Posted by Michael Wonder on 18 Dec 2016
AFT to re-apply for heart medicine contract after shortages
16 December 2016 - AFT Pharmaceuticals, the Auckland-based drug-maker, will have to re-apply to Pharmac for a heart medicine supply ...
Posted by Michael Wonder on 18 Dec 2016
PBS expenditure and prescriptions for 2015-16
16 December 2016 - The PBS Expenditure and Prescriptions Report 2015-16 is now available. ...
Posted by Michael Wonder on 18 Dec 2016
Proposal to list a range of orthopaedic implants and associated products supplied by Zimmer Biomet New Zealand
16 December 2016 - PHARMAC is seeking feedback on a proposal to list a range of orthopaedic implants and associated ...
Posted by Michael Wonder on 18 Dec 2016
New asthma treatments to be listed on Pharmaceutical Benefits Scheme
18 December 2016 - Life-saving new treatments for asthma that currently cost patients $700 a year will be listed on ...
Posted by Michael Wonder on 15 Dec 2016
NICE publishes second appraisal consultation document for brentuximab vedotin
15 December 2016 - The appraisal consultation relates to the use of brentuximab vedotin to treat patients with CD30 positive, ...
Posted by Michael Wonder on 15 Dec 2016
Price disclosure 2017 April cycle outcomes summary
15 December 2016 - The summary of price disclosure price reductions for the 2017 April cycle (second remove originator cycle) has ...
Posted by Michael Wonder on 15 Dec 2016
Decision relating to anti-VEGF treatments for ophthalmic use
15 December 2016 - On 5 September 2016, PHARMAC consulted on a proposal to list ranibizumab (Lucentis) and aflibercept (Eylea) ...
Posted by Michael Wonder on 15 Dec 2016
Review must avoid change for the sake of change
14 December 2016 - Call me a small “c” conservative if you like, but when it comes to community pharmacy ...
Posted by Michael Wonder on 14 Dec 2016
Life-saving cancer drug restricted
13 December 2016 - A British Colombia woman says a new immuno-oncology drug that saved her life is not available ...
Posted by Michael Wonder on 14 Dec 2016
NICE publishes final guidance on the use of AstraZeneca's Brilique
14 December 2016 - The guidance relates to the use of ticagrelor for the prevention of atherothrombotic events after myocardial ...
Posted by Michael Wonder on 14 Dec 2016
NICE and the FDA working together
14 December 2016 - NICE and the US FDA are working closely to help developers of medical devices, diagnostics, and ...
Posted by Michael Wonder on 14 Dec 2016
Patients call for funding of drugs for rare disorders
13 December 2016 - People with rare health disorders are urging MPs to consider whether extra funding is needed for potentially ...